{"entity":{"type":"insider","cik":"0001752940","url":"/insider/0001752940","json_url":"/insider/0001752940.json","name":"Kruse Bo","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":25,"n_filings":21,"first":"2020-05-15","last":"2024-05-31","span_basis":"filed_date"},"name_variants":[{"name":"Kruse Bo","source":"filing","n_filings":21,"first_seen":"2020-05-15","last_seen":"2024-05-31"}],"transactions":[{"id":3268504,"accession":"0001104659-24-067356","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-24-067356","line_url":"/filing/0001104659-24-067356#line-4","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, SECRY & TREAS)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, SECRY & TREAS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, SECRY & TREAS.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":31371.0,"shares_display":"31,371","price_per_share":12.07,"price_display":"12.07","price_state":"stated","total_value":378647.97,"total_display":"378,647.97","total_whole":"378,648","shares_owned_after":210877.0,"shares_owned_after_display":"210,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-31","filed_date":"2024-05-31","scope":"insider"},{"id":3268496,"accession":"0001104659-24-067356","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-24-067356","line_url":"/filing/0001104659-24-067356#line-2","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, SECRY & TREAS)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, SECRY & TREAS)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, SECRY & TREAS.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":28629.0,"shares_display":"28,629","price_per_share":12.03,"price_display":"12.03","price_state":"stated","total_value":344406.87,"total_display":"344,406.87","total_whole":"344,407","shares_owned_after":210877.0,"shares_owned_after_display":"210,877","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-05-30","filed_date":"2024-05-31","scope":"insider"},{"id":6882731,"accession":"0001104659-22-026182","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-026182","line_url":"/filing/0001104659-22-026182#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":7.85,"price_display":"7.85","price_state":"stated","total_value":31400.0,"total_display":"31,400.00","total_whole":"31,400","shares_owned_after":181077.0,"shares_owned_after_display":"181,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-22","filed_date":"2022-02-23","scope":"insider"},{"id":6648313,"accession":"0001104659-22-012870","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-012870","line_url":"/filing/0001104659-22-012870#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":7.97,"price_display":"7.97","price_state":"stated","total_value":31880.0,"total_display":"31,880.00","total_whole":"31,880","shares_owned_after":185077.0,"shares_owned_after_display":"185,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-04","filed_date":"2022-02-07","scope":"insider"},{"id":6648282,"accession":"0001104659-22-007441","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-007441","line_url":"/filing/0001104659-22-007441#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":9.84,"price_display":"9.84","price_state":"stated","total_value":39360.0,"total_display":"39,360.00","total_whole":"39,360","shares_owned_after":189077.0,"shares_owned_after_display":"189,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-24","filed_date":"2022-01-25","scope":"insider"},{"id":6475553,"accession":"0001104659-22-001565","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-22-001565","line_url":"/filing/0001104659-22-001565#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":17.12,"price_display":"17.12","price_state":"stated","total_value":68480.0,"total_display":"68,480.00","total_whole":"68,480","shares_owned_after":193077.0,"shares_owned_after_display":"193,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-04","filed_date":"2022-01-05","scope":"insider"},{"id":5142257,"accession":"0001104659-21-153184","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-153184","line_url":"/filing/0001104659-21-153184#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":16.36,"price_display":"16.36","price_state":"stated","total_value":65440.0,"total_display":"65,440.00","total_whole":"65,440","shares_owned_after":197077.0,"shares_owned_after_display":"197,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-22","filed_date":"2021-12-23","scope":"insider"},{"id":4130936,"accession":"0001104659-21-147273","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-147273","line_url":"/filing/0001104659-21-147273#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":16.35,"price_display":"16.35","price_state":"stated","total_value":65400.0,"total_display":"65,400.00","total_whole":"65,400","shares_owned_after":201077.0,"shares_owned_after_display":"201,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-06","filed_date":"2021-12-07","scope":"insider"},{"id":4282859,"accession":"0001104659-21-143090","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-143090","line_url":"/filing/0001104659-21-143090#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":18.09,"price_display":"18.09","price_state":"stated","total_value":72360.0,"total_display":"72,360.00","total_whole":"72,360","shares_owned_after":205077.0,"shares_owned_after_display":"205,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-22","filed_date":"2021-11-23","scope":"insider"},{"id":4584943,"accession":"0001104659-21-135122","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-135122","line_url":"/filing/0001104659-21-135122#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":27.54,"price_display":"27.54","price_state":"stated","total_value":110160.0,"total_display":"110,160.00","total_whole":"110,160","shares_owned_after":209077.0,"shares_owned_after_display":"209,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-11-04","filed_date":"2021-11-05","scope":"insider"},{"id":5206838,"accession":"0001104659-21-130079","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-130079","line_url":"/filing/0001104659-21-130079#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":25.94,"price_display":"25.94","price_state":"stated","total_value":103760.0,"total_display":"103,760.00","total_whole":"103,760","shares_owned_after":213077.0,"shares_owned_after_display":"213,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-22","filed_date":"2021-10-26","scope":"insider"},{"id":4949034,"accession":"0001104659-21-123198","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-123198","line_url":"/filing/0001104659-21-123198#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":28.78,"price_display":"28.78","price_state":"stated","total_value":115120.0,"total_display":"115,120.00","total_whole":"115,120","shares_owned_after":217077.0,"shares_owned_after_display":"217,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-10-04","filed_date":"2021-10-05","scope":"insider"},{"id":5404401,"accession":"0001104659-21-118852","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-118852","line_url":"/filing/0001104659-21-118852#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":30.82,"price_display":"30.82","price_state":"stated","total_value":123280.0,"total_display":"123,280.00","total_whole":"123,280","shares_owned_after":221077.0,"shares_owned_after_display":"221,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-22","filed_date":"2021-09-23","scope":"insider"},{"id":4720780,"accession":"0001104659-21-113880","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-113880","line_url":"/filing/0001104659-21-113880#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":32.03,"price_display":"32.03","price_state":"stated","total_value":128120.0,"total_display":"128,120.00","total_whole":"128,120","shares_owned_after":225077.0,"shares_owned_after_display":"225,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-09-07","filed_date":"2021-09-08","scope":"insider"},{"id":4844256,"accession":"0001104659-21-109000","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-109000","line_url":"/filing/0001104659-21-109000#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":28.6,"price_display":"28.60","price_state":"stated","total_value":114400.0,"total_display":"114,400.00","total_whole":"114,400","shares_owned_after":229077.0,"shares_owned_after_display":"229,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-23","filed_date":"2021-08-24","scope":"insider"},{"id":5206548,"accession":"0001104659-21-100844","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-100844","line_url":"/filing/0001104659-21-100844#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":33.72,"price_display":"33.72","price_state":"stated","total_value":134880.0,"total_display":"134,880.00","total_whole":"134,880","shares_owned_after":233077.0,"shares_owned_after_display":"233,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-04","filed_date":"2021-08-05","scope":"insider"},{"id":5051674,"accession":"0001104659-21-095581","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-095581","line_url":"/filing/0001104659-21-095581#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":34.5,"price_display":"34.50","price_state":"stated","total_value":138000.0,"total_display":"138,000.00","total_whole":"138,000","shares_owned_after":237077.0,"shares_owned_after_display":"237,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-22","filed_date":"2021-07-26","scope":"insider"},{"id":5404221,"accession":"0001104659-21-089877","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-089877","line_url":"/filing/0001104659-21-089877#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":34.15,"price_display":"34.15","price_state":"stated","total_value":136600.0,"total_display":"136,600.00","total_whole":"136,600","shares_owned_after":241077.0,"shares_owned_after_display":"241,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-07-06","filed_date":"2021-07-07","scope":"insider"},{"id":5282194,"accession":"0001104659-21-084646","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-084646","line_url":"/filing/0001104659-21-084646#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":36.17,"price_display":"36.17","price_state":"stated","total_value":144680.0,"total_display":"144,680.00","total_whole":"144,680","shares_owned_after":245077.0,"shares_owned_after_display":"245,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-22","filed_date":"2021-06-23","scope":"insider"},{"id":4987376,"accession":"0001104659-21-077698","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-077698","line_url":"/filing/0001104659-21-077698#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":33.48,"price_display":"33.48","price_state":"stated","total_value":133920.0,"total_display":"133,920.00","total_whole":"133,920","shares_owned_after":249077.0,"shares_owned_after_display":"249,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-04","filed_date":"2021-06-07","scope":"insider"},{"id":5206269,"accession":"0001104659-21-072451","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-21-072451","line_url":"/filing/0001104659-21-072451#line-1","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secretary & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secretary & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secretary & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4000.0,"shares_display":"4,000","price_per_share":35.61,"price_display":"35.61","price_state":"stated","total_value":142440.0,"total_display":"142,440.00","total_whole":"142,440","shares_owned_after":253077.0,"shares_owned_after_display":"253,077","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-24","filed_date":"2021-05-26","scope":"insider"},{"id":2397393,"accession":"0001104659-20-062623","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001104659-20-062623","line_url":"/filing/0001104659-20-062623","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secy & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secy & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secy & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":66046.0,"shares_display":"66,046","price_per_share":36.02647529600581,"price_display":"36.03","price_state":"stated","total_value":2379404.5874,"total_display":"2,379,404.59","total_whole":"2,379,405","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-14","filed_date":"2020-05-15","scope":"insider","n_lines":2},{"id":2397389,"accession":"0001104659-20-062623","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001104659-20-062623","line_url":"/filing/0001104659-20-062623","is_derivative":false,"issuer_cik":"0001722964","issuer_name":"Y-mAbs Therapeutics, Inc.","issuer_ticker":"YMAB","issuer_name_source":null,"issuer_url":"/issuer/0001722964","owner_cik":"0001752940","owner_name":"Kruse Bo","owner_display_name":"Kruse Bo","owner_url":"/insider/0001752940","role":"Officer (EVP, CFO, Secy & Treas)","role_mark":"O","role_mark_label":"Officer (EVP, CFO, Secy & Treas)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"EVP, CFO, Secy & Treas.","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":33954.0,"shares_display":"33,954","price_per_share":37.87231569181834,"price_display":"37.87","price_state":"stated","total_value":1285916.607,"total_display":"1,285,916.61","total_whole":"1,285,917","shares_owned_after":37847.0,"shares_owned_after_display":"37,847","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-05-13","filed_date":"2020-05-15","scope":"insider","n_lines":2}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":25,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":25,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":25},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001722964","name":"Y-mAbs Therapeutics, Inc.","url":"/issuer/0001722964","role":"Officer (EVP, CFO, SECRY & TREAS)","n_filings":21,"first_seen":"2020-05-15","last_seen":"2024-05-31"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001752940","retrieved_at":"2026-08-26T08:47:43+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}